At Deltex Medical, we’re driven by a clear mission: to combat haemodynamic instability and help clinicians improve patient outcomes worldwide. As a global leader in advanced haemodynamic monitoring, we proudly partner anaesthetists and critical care specialists to reduce preventable complications and elevate standards of care.

Introducing TrueVue™ – Advanced Insights. Better Outcomes.

At the core of our innovation is TrueVue™, the next generation in haemodynamic monitoring, built around our enhanced Oesophageal Doppler Monitoring (ODM) technology. TrueVue™ integrates superior Doppler signal acquisition with Pulse Pressure Wave Analysis, providing comprehensive, real-time data for better informed clinical decisions.

Why TrueVue™?

• Unmatched Accuracy: Real-time, beat-to-beat data on Stroke Volume, Cardiac Output, Systemic Vascular Resistance, Oxygen Delivery, and Inotropy Index.
• Enhanced Patient Safety: Supports clinicians in reducing the risk of complications such as acute kidney injury, acute respiratory distress syndrome, and heart failure.
• Versatility in Critical Care: Optimise preload, afterload, and contractility in complex scenarios, including sepsis, trauma, and burns.
• User-Centred Design: Advanced data in an intuitive, easy-to-use format.

For more information, please visit www.deltexmedical.com